Effect of clofibrate in low birth weight neonates' hyperbilirubinemia

Phase 2

• Conditions: Condition 1: low birth weight. Condition 2: hyperbilirubinemia.; Other low birth weight; Neonatal jaundice associated with preterm delivery

• Registration Number: IRCT138708291162N8
• Lead Sponsor: mashhad university of medical science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

All neonates with birth weight less than 2500gr who have icter.
Exclusion criteria: the presence of a hemolytic, infection, congenital anomaly or metabolic disorder and undergoing mechanical ventilation.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Decreasing of serum bilirubin. Timepoint: befor intervention and 12,24,48,72 and 96 hours after intervention. Method of measurement: measurment of serum bilirubin (diazo method).

Secondary Outcome Measures

Name	Time	Method
Tereatment of jaundice of neonate. Timepoint: befor intervention and 24,48,72 and 96 hours after intervention. Method of measurement: decreasing of jaundice and bilirubin level in blood serum.